The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more
than four weeks after primary infection, termed “long COVID” or post-acute sequela of …

The occurrence of anosmia, the loss or change in sense of smell, is one of the most common
symptoms of COVID-19 experienced by almost 53% of those affected. Several hypotheses …

The acute loss of taste and smell following COVID-19 are hallmark symptoms that affect 20–
85% of patients. However, the pathophysiology and potential treatments of COVID-19 smell …

Objectives Anosmia is a common debilitating symptom of the novel coronavirus disease
2019 (COVID-19). Currently, there is no satisfactory treatment of anosmia. Therefore, this …

Abstract Purpose of Review Olfactory dysfunction is a frequent complication of SARS-CoV-2
infection. This review presents the current literature regarding the management of post …

The aim of this study was to evaluate the usage of mometasone furoate nasal spray in the
recovery of patients with severe microsmia or anosmia induced by COVID-19. This was a …

Background Loss of olfactory function is well recognised as a symptom of COVID‐19
infection, and the pandemic has resulted in a large number of individuals with abnormalities …

Background and Aims Olfactory dysfunction is a recognized manifestation in patients
infected with Coronavirus Disease 2019 (COVID‐19). This investigation aimed to assess the …

SARS-CoV-2 infects host cells mainly through the interaction between the virus's Spike
protein and the viral receptors namely Angiotensin-Converting Enzyme 2 (ACE2) and …

Background The COVID-19 pandemic has produced a myriad of challenges, including
identifying and treating neurological sequelae. Main body COVID-19 can cause olfactory …